Skip to main content
. 2017 Aug 29;2017:1478625. doi: 10.1155/2017/1478625

Figure 4.

Figure 4

Dose-dependent inhibition of C. trachomatis growth in B10.MLM cells at 42 hpi in the presence of microencapsulated lycopene. (a) C. trachomatis infection in B10.MLM cells at 42 h.p.i. (1) growth in the presence of 1.0% cyclodextrin; (2) growth in the presence of 0.125 mg/ml; (3) 0.25 mg/ml; and (4) 0.5 mg/ml of microencapsulated lycopene. Scale bar 100 µm. (b) Quantitative representation of the inclusion numbers of control and lycopene treated cells. IFU/FOV = Average Inclusion Forming Units per Field of View (n = 20). (c) Infectious yield after treatment with different doses of lycopene.